Article
Alternative Splicing Role in New Therapies of Spinal Muscular Atrophy
28 Aug 2021
Abstract excerpt
It has been estimated that 80% of the pre-mRNA undergoes alternative splicing, which exponentially increases the flow of biological information in cellular processes and can be an attractive therapeutic target. It is a crucial mechanism to increase genetic diversity. Disturbed alternative splicing is observed in many disorders, including neuromuscular diseases and carcinomas. Spinal Muscular Atrophy (SMA) is an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
